Jason Butler
Stock Analyst at Citizens JMP
(4.79)
# 530
Out of 4,429 analysts
759
Total ratings
49.8%
Success rate
16.7%
Average return
Main Sectors:
Stocks Rated by Jason Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZVRA Zevra Therapeutics | Maintained: Buy | $18 → $25 | $12.65 | +97.63% | 10 | Jun 9, 2026 | |
| RZLT Rezolute | Upgraded: Buy | $11 | $5.15 | +113.59% | 33 | Jun 3, 2026 | |
| ABVX ABIVAX Société Anonyme | Maintained: Buy | $131 → $187 | $101.66 | +83.95% | 14 | Jun 2, 2026 | |
| GHRS GH Research | Maintained: Buy | $42 → $39 | $21.85 | +78.49% | 24 | May 15, 2026 | |
| PGEN Precigen | Maintained: Buy | $9 → $11 | $5.38 | +104.46% | 49 | May 14, 2026 | |
| AVTX Avalo Therapeutics | Maintained: Buy | $62 → $55 | $17.08 | +222.01% | 3 | May 14, 2026 | |
| PRTA Prothena Corporation | Maintained: Buy | $19 → $20 | $9.15 | +118.58% | 27 | May 8, 2026 | |
| NERV Minerva Neurosciences | Initiated Coverage: Buy | $14 | $4.66 | +200.43% | 19 | Apr 15, 2026 | |
| NSRX Nasus Pharma | Maintained: Buy | $19 → $18 | $3.12 | +476.92% | 2 | Mar 26, 2026 | |
| ARGX argenx SE | Maintained: Buy | $699 → $944 | $903.75 | +4.45% | 42 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $35 | $22.09 | +58.44% | 48 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $10 | $3.82 | +161.78% | 19 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $88 → $96 | $79.17 | +21.26% | 62 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $5.10 | +272.55% | 1 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $77 → $80 | $38.19 | +109.48% | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $91 → $92 | $68.99 | +33.35% | 48 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $12 | $4.72 | +154.24% | 53 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $3.16 | +26.58% | 49 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $22 | $8.82 | +149.43% | 43 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.25 | n/a | 34 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $38 | $17.63 | n/a | 29 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.011 | n/a | 38 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 31 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.205 | n/a | 13 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9206 | n/a | 8 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.41 | n/a | 9 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 5 | Sep 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.25 | n/a | 5 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €366.99 | $793.60 | n/a | 1 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $70 | $87.44 | n/a | 3 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.66 | n/a | 7 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.11 | n/a | 3 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $6.00 | n/a | 8 | Feb 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.25 | n/a | 1 | Oct 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $374.04 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.89 | n/a | 5 | May 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $2 | $40.53 | n/a | 2 | Aug 16, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $8.53 | n/a | 1 | May 22, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.51 | n/a | 2 | May 6, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.16 | n/a | 1 | Mar 26, 2013 |
Zevra Therapeutics
Jun 9, 2026
Maintained: Buy
Price Target: $18 → $25
Current: $12.65
Upside: +97.63%
Rezolute
Jun 3, 2026
Upgraded: Buy
Price Target: $11
Current: $5.15
Upside: +113.59%
ABIVAX Société Anonyme
Jun 2, 2026
Maintained: Buy
Price Target: $131 → $187
Current: $101.66
Upside: +83.95%
GH Research
May 15, 2026
Maintained: Buy
Price Target: $42 → $39
Current: $21.85
Upside: +78.49%
Precigen
May 14, 2026
Maintained: Buy
Price Target: $9 → $11
Current: $5.38
Upside: +104.46%
Avalo Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $62 → $55
Current: $17.08
Upside: +222.01%
Prothena Corporation
May 8, 2026
Maintained: Buy
Price Target: $19 → $20
Current: $9.15
Upside: +118.58%
Minerva Neurosciences
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $4.66
Upside: +200.43%
Nasus Pharma
Mar 26, 2026
Maintained: Buy
Price Target: $19 → $18
Current: $3.12
Upside: +476.92%
argenx SE
Feb 27, 2026
Maintained: Buy
Price Target: $699 → $944
Current: $903.75
Upside: +4.45%
Feb 26, 2026
Maintained: Buy
Price Target: $38 → $35
Current: $22.09
Upside: +58.44%
Feb 26, 2026
Maintained: Buy
Price Target: $8 → $10
Current: $3.82
Upside: +161.78%
Feb 25, 2026
Maintained: Buy
Price Target: $88 → $96
Current: $79.17
Upside: +21.26%
Nov 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $5.10
Upside: +272.55%
Nov 7, 2025
Maintained: Buy
Price Target: $77 → $80
Current: $38.19
Upside: +109.48%
Nov 4, 2025
Maintained: Buy
Price Target: $91 → $92
Current: $68.99
Upside: +33.35%
Oct 9, 2025
Maintained: Buy
Price Target: $9 → $12
Current: $4.72
Upside: +154.24%
Sep 22, 2025
Reiterated: Buy
Price Target: $4
Current: $3.16
Upside: +26.58%
Sep 9, 2025
Reiterated: Buy
Price Target: $19 → $22
Current: $8.82
Upside: +149.43%
May 12, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.25
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $42 → $38
Current: $17.63
Upside: n/a
Dec 27, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.011
Upside: n/a
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 3, 2023
Rated: Hold
Price Target: n/a
Current: $0.205
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $0.9206
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $4.41
Upside: n/a
Sep 3, 2021
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $2.25
Upside: n/a
Feb 1, 2021
Maintained: Buy
Price Target: €366.99
Current: $793.60
Upside: n/a
Jan 9, 2020
Maintained: Buy
Price Target: $58 → $70
Current: $87.44
Upside: n/a
Sep 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.66
Upside: n/a
Mar 28, 2019
Downgraded: Hold
Price Target: n/a
Current: $4.11
Upside: n/a
Feb 14, 2019
Reiterated: Buy
Price Target: $52
Current: $6.00
Upside: n/a
Oct 18, 2016
Reiterated: Buy
Price Target: $17
Current: $3.25
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $61
Current: $374.04
Upside: n/a
May 10, 2016
Reiterated: Hold
Price Target: n/a
Current: $3.89
Upside: n/a
Aug 16, 2013
Reiterated: Buy
Price Target: $6 → $2
Current: $40.53
Upside: n/a
May 22, 2013
Initiated Coverage: Hold
Price Target: n/a
Current: $8.53
Upside: n/a
May 6, 2013
Downgraded: Hold
Price Target: n/a
Current: $11.51
Upside: n/a
Mar 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $2.16
Upside: n/a